RTG 1694, entitled "Elementary Particle Physics at Highest Energy and Precision", will perform research into experimental and theoretical particle physics. This RTG's research profile is based on the latest developments in this field. Planned experiments will involve the Large Hadron Collider (LHC), which has been generating highest levels of energy since March 2010, as well as other large-scale international experiments, and will mean exploring uncharted physics territory. The experiments involving the LHC are aimed at discovering new particles like the Higgs boson, as well as potential supersymmetric particles. This RTG will also focus on rare beta disintegrations and determining the absolute neutrino mass. Further important aspects include the development of improved methods of analysis and detectors in LHC and flavour physics.
(Coordinating institution: Karlsruhe Institute of Technology (KIT): Coordinator: Professor Dr. Dieter Zeppenfeld)
Linking basic research into autoimmunity with targeted clinical applications is the focus of RTG 1727 "Modulating Autoimmunity." Autoimmune diseases are becoming more and more frequent but despite recent findings clarifying their causes, therapy usually still involves an unspecified suppression of the immune system. The successful translation of these findings into innovative therapeutic strategies, therefore, is one of the key challenges facing clinically relevant autoimmune research. The new RTG's research programme involves the development of strategies for treating known a
|Contact: Marco Finetti|